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Background: Evidence has shown that single nucleotide polymorphism located in pre-miRNA or mature microRNA
may modify various biological processes and affect the processing of carcinogenesis. Published results about the
association between miR-146a rs2910164 G/C polymorphism and human gastric cancer susceptibility are inconclusive.
The aim of this study was to acquire a more precise effect of the association between the miR-146a rs2910164
polymorphism and gastric risk by meta-analysis.
Methods: Eligible genetic association studies were searched from PubMed, Web of Knowledge and Chinese
Biomedicine Database on human subject. Quantitative data synthesis was conducted for the associations of
miR-146a rs2910164 G/C polymorphism with susceptibility to gastric cancer.
Results: Nine eligible studies that included a total of 3,885 gastric cancer patients and 5,396 controls were
identified in the present meta-analysis. The overall OR indicated a potential association between rs2910164
polymorphism and GC but the effect was not statistically significant (GG vs. CG/CC: OR = 1.076, 95% CI 0.925-1.251,
P = 0.342). When stratifying for population, the result showed that miR-146a rs2910164 GG genotype was associated
with increased gastric cancer risk among Chinese in recessive model (GG vs. CG/CC: OR = 1.171, 95% CI 1.050-1.306,
P = 0.005). Besides, no significant difference was found in gender, smoking, location, metastasis of lymph node and
Laurèn’s classification.
Conclusions: The present meta-analysis suggests an increased risk between miR-146a rs2910164 GG genotype and
gastric cancer susceptibility in Chinese based on published literatures.
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Gastric cancer (GC) is still one of the most common
causes of cancer-related death worldwide despite an
overall decrease in incidence over the past 10 years [1,2].
It is generally accepted that individual genetic suscepti-
bility has an important role in the pathogenesis of tumor
including GC.
MicroRNAs (miRNAs/miR) are endogenous 18–24
nucleotide noncoding RNAs that could regulate gene
expression and sequentially regulate various biological
processes [3,4]. Functional characterization of some micro-
RNAs in cancer initiation and progression indicates that* Correspondence: caohui912@hotmail.com
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unless otherwise stated.they might play a more important role in the pathogenesis
of human cancers [5,6]. The relationship between miRNA
and cancer has been extensively studied since 2002, the
first demonstration of a link between miRNA genes and
cancer [7].
Studies have shown that the polymorphisms in pre-
miRNA or mature microRNA may modify various bio-
logical processes by influencing the expression and/or
target selection of microRNAs [8,9]. Over the past
decade, numerous studies identified genetic variants in
the precursor or mature miRNA sequence of miR-146a
rs2910164 (G > C), which have been reported to be
associated with breast cancer and hepatocellular carcin-
oma [10,11].
A number of studies were published to describe the as-
sociation between miR-146a rs2910164 G/C polymorph-
ism and cancer risk in recent years. A meta-analysisThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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zygote of rs2910164 may contribute to breast cancer
susceptibility among Europeans. Another meta-analysis
demonstrated that there is no significant correlation be-
tween has-miR-146a rs2910164 polymorphism and breast
cancer risk [12]. A HuGE meta-analysis in 2013 failed to
find any significant association between rs2910164 poly-
morphism and the risk of breast cancer [13]. Based on
systematic review, Chen et al. [14] reported that quality of
evidence was low for rs2910164 SNP genetic association
with lung cancer. Several meta-analyses pooled the associ-
ation between rs2910164 polymorphism and cancer risk
in general [15,16]. Some meta-analysis reported the
rs2910164 polymorphism and gastrointestinal cancer sus-
ceptibility [17-19].Figure 1 Flow chart of Studies inclusion and exclusion.However, published data on the association between
miR-146a rs2910164 G/C polymorphism and human
gastric cancer susceptibility are inconsistent and inconclu-
sive. Therefore, we performed the present meta-analysis to
quantitatively estimate the association of miR-146a G/C
SNP with gastric cancer risks.
Methods
Literature search strategy
Electronic databases including PubMed, Web of Knowledge
and Chinese Biomedicine Database (CBM) were searched
for relevant studies conducted on human subject until July
2014. The following search keywords were used: “gastric”
or “stomach”, “neoplasm” OR “carcinoma” OR “cancer”
OR “tumor” OR “adenocarcinoma” and “miR-146a OR









Cases Controls PHWE for
controlCC CG GG CC CG GG
Okubo 2010 Japan PCR-RFLP 552 697 236 243 73 254 322 121 0.2776
Zeng 2010 China PCR-RFLP 304 304 89 153 62 119 132 53 0.1223
Hishida 2011 Japan PCR-CTPP 583 1637 230 271 82 633 775 229 0.7381
Zhou F 2012 China TaqMan MGB 1686 1895 286 822 578 393 951 551 0.6407
Zhou Y 2012 China Locus-specific PCR 299 416 107 146 46 127 215 74 0.301
Ahn 2013 Korea PCR-RFLP 461 447 159 231 71 164 221 62 0.3618
Dikeakos 2014 Greece PCR-RFLP 163 480 105 45 13 307 149 24 0.2892
Kupcinskas 2014 Europe Real Time-PCR 362 347 16 94 252 16 108 223 0.5311
Pu 2014 China PCR-RFLP 197 513 65 96 36 143 274 96 0.0801
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146a”. To further identify potentially relevant studies,
the reference lists of articles identified in the initial
search were also scanned manually. We directly con-
tacted authors for related data that were unavailable in
the original publications.
Inclusion and exclusion criteria
Studies were considered eligible if they met all of the fol-
lowing criteria: (1) explore the association between miR-
146a polymorphism and human GC risk, (2) design as
case–control studies, (3) identification of gastric cancer
cases was confirmed histologically or pathologically.
Studies were excluded based on any of the following
reasons: (1) no sufficient data reported, (2) articles of let-
ters, reviews, case reports, conference abstracts, editorialsTable 2 Meta-analysis of miR-146a rs2910164 polymorphism




Asian GG vs. CC 7 1.016(0.7




GG vs. CG/CC 1.025(0.8
G vs. C 1.006(0.8
European GG vs. CC
2
1.331(0.8
CG vs. CC 0.880(0.6
CG/GG vs. CC 0.994(0.7
GG vs. CG/CC 1.326(0.9
G vs. C 1.146(0.9
Overall GG vs. CC 9 1.056(0.8
CG vs. CC 0.984(0.8
CG/GG vs. CC 1.005(0.8
GG vs. CG/CC 1.076(0.9
G vs. C 1.028(0.9or expert opinion. If serial studies of the same population
from the same research group were published, only the
largest series were selected.
Data extraction
The final set of articles was assessed independently by
two reviewers (Zhong Xu and Lingling Zhang) according
to the inclusion criteria listed above. Disagreements were
resolved by discussion. The following information was re-
trieved from each report: first author, publication year,
study population, ethnicity, number of GC cases and con-
trols, frequency of genotypes, and genotyping method.
Statistical analysis
Hardy–Weinberg equilibrium (HWE) status was exam-
ined by Pearson’s goodness-of-fit χ2 test in each studywith gastric cancer by population
association Test of heterogeneity
CI) P P (Q-test) I2
80, 1.324) 0.906 0.000 75.2%
47, 1.176) 0.982 0.014 62.2%
30, 1.216) 0.962 0.001 75.1%
61, 1.221) 0.779 0.036 55.6%
77, 1.153) 0.935 0.000 78.7%
02, 2.210) 0.269 0.512 0.0%
19, 1.253) 0.478 0.973 0.0%
16, 1.380) 0.971 0.875 0.0%
95, 1.767) 0.054 0.512 0.0%
37, 1.401) 0.184 0.608 0.0%
36, 1.334) 0.649 0.001 68.1%
53, 1.136) 0.830 0.037 51.3%
52, 1.184) 0.956 0.002 66.9%
25, 1.251) 0.342 0.052 48.0%
14, 1.155) 0.648 0.000 72.5%
Figure 2 Meta-analysis of miR-146a rs2910164 polymorphism and gastric cancer susceptibility for recessive model (GG vs. CG + CC).
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the control group). The strength of the association be-
tween GC and the miR-146a rs2910164 polymorphism
was assessed by calculating odds ratio (OR) with 95%
confidence interval (CI). The pooled ORs were obtained
from combination of single studies by homozygote com-
parison (GG vs. CC), heterozygote comparison (CG vs.
CC), dominant and recessive models (CG/GG vs. CC,
and GG vs. CG/CC), allele comparison (G vs. C), re-
spectively. The analysis of heterogeneity between studies
was determined by using the Cochrane’s Q test and I2-
test (P <0.10 or I2 > 50% was considered indicative of
statistically heterogeneity) [20]. When there was no sig-
nificant heterogeneity existing among studies, the pooled
ORs estimate of each study was calculated by the fixed-
effects model. Otherwise, the random-effects model was
employed. Subgroup analyses were stratified by the study
characteristic if there were enough reports. Sensitivity
analysis was carried out by deleting one single study
each time to examine the influence of individual data setTable 3 Meta-analysis of miR-146a rs2910164
polymorphism with gastric cancer in Chinese
Comparison Test of association Test of heterogeneity
OR (95% CI) P P (Q-test) I2
GG vs. CC 1.113(0.773, 1.604) 0.564 0.011 73.1%
CG vs. CC 1.045(0.783, 1.394) 0.766 0.012 72.8%
CG/GG vs. CC 1.065(0.779, 1.457) 0.692 0.002 79.4%
GG vs. CG/CC 1.193(1.057, 1.346) 0.004 0.201 35.1%
G vs. C 1.055(0.868, 1.283) 0.590 0.004 77.8%on the pooled ORs. Publication bias was assessed by
using the methods of Begg’s funnel plots and Egger’s test
(P <0.05 was considered representative of statistically sig-
nificant publication bias) [21,22]. Statistical analyses per-
formed by using the software Stata12.0 (Stata Corpotion,
College Station, Texas).
Results
Studies selection and characteristics of the included
studies
A total of 288 articles were identified from the PubMed,
ISI and CBM database. The flow chart summarizes the
literature review process as shown in Figure 1. A total of
nine studies involving 3,885 GC cases and 5,396 controls
were ultimately pooled for the present meta-analysis
[23-31]. The characteristics of these studies are listed in
Table 1. Among them, seven studies were performed in
Asia (including patients from China, Japan and Korea),
two studies in Europe (including patients from Greece,
Germany, Lithuania and Latvia). Article by Okubo et al.
[32] was excluded because of the duplication with
another study [23]. All of the included articles were
hospital-based case–control studies. The distribution of
genotypes in the controls of all nine studies was in
agreement with HWE.
Quantitative data synthesis
The summary of this meta-analysis for the association
between miR-146a rs2910164 G/C polymorphism and
the susceptibility of gastric cancer were shown in
Table 2. Overall, there was no significant association
Figure 3 Meta-analysis of miR-146a rs2910164 polymorphism and gastric cancer susceptibility in Chinese for recessive model
(GG vs. CG + CC).
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control by combining the nine studies. The random-
effects model was used to pool these results as statisti-
cally heterogeneity was observed between studies
(P Q-test <0.1, I
2 > 50%). The pooled OR estimates
of the meta-analyses were often greater than 1.00,
indicating a potential association of rs2910164 poly-
morphism and GC although this effect was not statis-
tically significant. For recessive model, as PQ-test <0.1
by heterogeneity analysis, also the random-effects
model was used for analysis. As shown in Figure 2,
there was no statistically increased risk of gastric can-
cer in recessive model when pooled the nine studies
(recessive model, GG vs. CG/ CC: OR = 1.076, 95% CI
0.925-1.251, P = 0.342).
However, as shown in Table 3 and Figure 3, when we
performed subgroup analysis by location, the com-
bined result showed that miR-146a rs2910164 GG
genotype was associated with increased gastric cancer riskTable 4 Meta-analysis of rs2910164 polymorphism with GC b
Parameters Comparison No
stu
Gender CC vs. GG/CG 4
(Male vs. Female) CC/CG vs. GG 4
Smoking (No vs. Yes) CC vs. CG/GG 2
Site (Cardic vs. Non-Cardic) CC vs. CG/GG 4
CC/CG vs. GG 4
Metastasis of lymph node (Negative vs. Positive) CC vs. CG/GG 2
Laurèn’s classification (Intestinal vs. Diffuse) CC/CG vs. GG 4in China for recessive model (GG vs. CG/ CC: OR =
1.193, 95% CI 1.057-1.346, P = 0.004). In addition, interac-
tions between miR-146a polymorphism and clinicopatho-
logical characters were also conducted when usable data
obtained. No significant association between miR-146a
genetic variant and gastric cancer risk were found in the
stratified analysis by gender, smoking, location, metastasis
of lymph node and Laurèn’s classification (Table 4).
Sensitivity analysis and publication bias
We use one-way sensitivity analysis to evaluate the sta-
bility of the result in China [33]. In recessive model, the
sensitivity analysis of pooled OR with 95%CI changed
from 1.193(1.057, 1.346) to 0.995(0.786, 1.260) when
omitting one study by Zhou F [26] (Figure 4). The corre-
sponding pooled OR was not materially altered in other
genetic models.
Begg’s funnel plot (Figure 5) and Egger’s test (Figure 6)
indicated no potential publication bias (P = 1.000 andy Clinicopathological characters
. of
dy
Test of association Test of heterogeneity
OR (95% CI) P P(Q-test) I2
0.916 (0.691, 1.215) 0.542 0.201 37.7%
0.939 (0.767, 1.148) 0.538 0.967 0.0%
0.843 (0.554, 1.282) 0.425 0.315 0.9%
0.844 (0.593, 1.201) 0.346 0.382 0.0%
0.897 (0.738, 1.090) 0.274 0.549 0.0%
1.211(0.842, 1.742) 0.302 0.589 0.0%
0.961(0.807, 1.145) 0.658 0.655 0.0%
Figure 4 The influence of each study by omission of individual
studies in China for recessive model.
Figure 6 Egger’s publication bias plot.
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http://www.biomedcentral.com/1471-2350/15/1170.355, respectively). The funnel plots showed some asym-
metry, which is probably due to the limited number of
studies.
Discussion
MiR-146a has been shown to play an important role in
cell proliferation, differentiation, apoptosis and tumori-
genesis [34-37]. Study by Jazdzewski et al. [38] in 2008
has suggested that rs2910164, a common polymorphism
in the pre-miR-146a sequence, could alter mature miR-
146a expression and play a role in the tumorigenesis. In
the past three years, a number of meta-analyses and re-
view pooled the association between rs2910164 G > C
polymorphism and cancer risk including gastrointestinal
tumors broadly [15-19,39-43]. Nine of them have evalu-
ated the association between rs2910164 polymorphism
and gastric cancer risk. With the same results, all of
them concluded no significant association between
rs2910164 polymorphism and gastric cancer.
Still why we performed this meta-analysis concerning
the miR-146a polymorphism in gastric cancer suscepti-
bility? Firstly, as shown in Table 5, the included studiesFigure 5 Begg’s funnel plot with pseudo 95% confidence limits.were limited in all of these meta-analyses regarding gas-
tric cancer. All of them excluded the study by Zhou Y
et al. [27] because of absence data in the article. Among
them, meta-analysis by Xu X et al. [19] included six re-
searches [23-26,28,44] to evaluate the association between
rs2910164 polymorphism and gastric cancer risk. How-
ever, one of the six included articles detected rs2910164
polymorphism from gastritis [44], not gastric cancer.
Then, none of the nine meta-analyses evaluated the miR-
146a rs2910164 G >C polymorphism and gastric cancer
susceptibility in details. Moreover, it is general that
esophageal cancer, liver cancer, gastric cancer, cervical
cancer and other malignancies have too distinct molecular
mechanisms and logically they do not seem to harbor a
common polymorphism as a risk factor. Similarly, esopha-
geal cancer, gastric cancer and colorectal cancer are not al-
ways consistent with each other in this term. Last but not
least, an update is needed to evaluate the association be-
tween rs2910164 G >C polymorphism and gastric cancer
risk. Therefore, we try to acquire a more precise assess-
ment of the association between rs2910164 polymorphism
and gastric risk.Table 5 Meta-analyses of rs2910164 polymorphism and
cancer risk (information about GC)
First author Year Included study about gastric cancer
[24] [25] [26] [28] [23] [44]
Srivastava [15] 2012 √ √ √ √
Wang J [16] 2012 √ √ √
Wang F [17] 2012 √ √ √
Wu [18] 2013 √ √ √
Xu X [19] 2014 √ √ √ √ √ √
Qiu [40] 2011 √ √ √
He [41] 2012 √ √ √ √
Xu Y [42] 2013 √ √ √ √
Yin [43] 2013 √ √ √ √
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present meta-analysis showed that the miR-146a GG
genotype was associated with increased risk of gastric
cancer in China subgroup in recessive model (pooled
OR = 1.193). There were no significant differences in
gender, smoking, location, metastasis of lymph node and
Laurèn’s classification across genotypes.
Of the nine studies included, studies by Zeng et al.
[24] and Zhou F et al. [26] describe distribution of geno-
type in gastric cancer by age. The former demonstrated
that rs2910164 GC/GG genotype had a increased risk of
gastric cancer especially in younger individuals aged
(≤58 years), the later showed that GG genotype in-
creased gastric cancer risk was more evident in younger
subjects (≤65 years). Zhou Y et al. [27] did not find any
differennt distribution in gastric cancer between differ-
ent tumor size (<5 cm vs. ≥5 cm). In addition, Zeng et al.
[24] reported no statistically significant association in
the variant genotypes with tumor differentiation. Almost
all of included studies were conducted in Asia except
two studies were in Europe. The study by Kupcinskas
et al. in Europe [30] analyzed gene polymorphisms of
miR-146a in 995 subjects including Germany, Latvia and
Lithuania. Data analysis showed that gene polymor-
phisms of miR-146a are not associated with risk of GC
in Europe. Besides, no difference between diffuse and
intestinal-type gastric cancer groups was found.
The results should be interpreted with carefulness be-
cause of several limitations. First, the limited patient
numbers may have influence the outcomes. Although we
conducted comprehensive literature research from mul-
tiple databases with no restriction in publication lan-
guages, dates, ethnicities and other factors, there were
only a total of nine studies involving 3,885 gastric cancer
cases and 5,396 controls for the present meta-analysis.
The overall OR indicated a potential association between
rs2910164 polymorphism and GC but the effect was not
statistically significant. It is still hard to make a firm con-
clusion about the accuracy of association between miR-
146a rs2910164 G > C polymorphism and gastric cancer
susceptibility. Second, we use one-way sensitivity ana-
lysis to evaluate the stability of the meta-analysis and the
result altered when omitting the study with the largest
samples. Third, only a few included researches reported
data of interactions between miR-146a polymorphism
and clinicopathological characters in gastric cancer, and
all of the pooled analysis of interactions was limited by
small sample size and deficit of data.
Conclusion
In conclusion, the present meta-analysis suggests an in-
creased risk between miR-146a rs2910164 GG genotype
and gastric cancer susceptibility in Chinese based on
published literatures. Further studies on a large scalemay be needed to confirm the genetic susceptibility of
miR-146a rs2910164 in gastric cancer.
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